⭐️⭐️⭐️⭐️⭐️ "A total no brainer"

⭐️⭐️⭐️⭐️⭐️ "Love this, so easy."

Spots is the easy way to track your skin, mole and cancer changes.

Spots Global Cancer Trial Database for A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: A Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Previously Untreated Metastatic Colorectal Cancer

Official Title: A Phase II, Randomized, Open-label, Controlled, Dose-elevation, Multicenter Trial of an Investigational Drug for the Prevention of Diarrhea Associated With Irinotecan/5FU/Leucovorin Chemotherapy in Patients With Previously Untreated Metastatic Colorectal Cancer

Study ID: NCT00040391

Study Description

Brief Summary: The study will combine a new investigational drug with standard anti-cancer drugs for the treatment of advanced colorectal cancer. The standard and approved treatment for colorectal cancer is to undergo chemotherapy with a combination of irinotecan (also known as CPT-11, Camptosar), 5-fluorouracil (also known as 5-FU), and leucovorin (also known as LV). This is known as the triple therapy. One of the major side effects of CPT-11/5-FU/LV chemotherapy treatment is diarrhea. The purpose of this research study is to see whether adding this investigational drug to the standard treatment for advanced colorectal cancer can reduce the amount of diarrhea a patient experiences. This study will also determine if adding the investigational drug to triple therapy has a positive effect on tumors.

Detailed Description:

Keywords

Eligibility

Minimum Age: 18 Years

Eligible Ages: ADULT, OLDER_ADULT

Sex: ALL

Healthy Volunteers: No

Locations

Research Center, Little Rock, Arkansas, United States

Research Center, Anaheim, California, United States

Research Center, Concord, California, United States

Research Center, Gilroy, California, United States

Research Center, Los Angeles, California, United States

Research Center, Jacksonville, Florida, United States

Research Center, New Port Richey, Florida, United States

Research Center, New Orleans, Louisiana, United States

Research Center, Scarborough, Maine, United States

Research Center, Pittsfield, Massachusetts, United States

Research Center, East Lansing, Michigan, United States

Research Center, St. Joseph, Michigan, United States

Research Center, Minneapolis, Minnesota, United States

Research Center, St. Joseph, Missouri, United States

Research Center, Las Vegas, Nevada, United States

Research Center, East Setauket, New York, United States

Research Center, Northport, New York, United States

Research Center, Burlington, North Carolina, United States

Research Center, Greenville, North Carolina, United States

Research Center, Zanesville, Ohio, United States

Research Center, Lancaster, Pennsylvania, United States

Research Center, Philadelphia, Pennsylvania, United States

Research Center, Charleston, South Carolina, United States

Research Center, Charleston, South Carolina, United States

Research Center, Germantown, Tennessee, United States

Research Center, Dallas, Texas, United States

Research Center, Madison, Wisconsin, United States

Research Center, Milwaukee, Wisconsin, United States

Contact Details

Useful links and downloads for this trial

Clinicaltrials.gov

Google Search Results

Logo

Take Control of Your Skin and Body Changes Today.

Try out Spots for free, set up only takes 2 mins.

spots app storespots app store

Join others from around the world: